Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Aline Gillain"'
Autor:
Zuzana Javorcikova, Michel Dangoisse, Stéphane Nikis, Jean-Paul Lechat, Aline Gillain, Jean-François Fils, Philippe Van der Linden
Publikováno v:
Trials, Vol 22, Iss 1, Pp 1-11 (2021)
Abstract Background Fibromyalgia is a chronic multidimensional pain disease with no curative treatment currently available. Its management relies on a multimodal approach involving pharmacologic and non-pharmacologic elements. Because a suggested fac
Externí odkaz:
https://doaj.org/article/569b0e77782f454b8c7756c330a5a05b
Autor:
Nathalie de Visscher, Xavier Holemans, Aline Gillain, Anne Kornreich, Raphael Lagasse, Philippe Piette, Manfredi Ventura, Frédéric Thys
Publikováno v:
Viruses, Vol 14, Iss 7, p 1535 (2022)
Background: The Grand Hôpital de Charleroi is a large non-academic Belgian hospital that treated a large number of COVID-19 inpatients. In the context of this pandemic, all professions-combined healthcare workers (HCWs), and not only direct caregive
Externí odkaz:
https://doaj.org/article/b52cd458d3ca4b508c002081effa4583
Autor:
Jean-François Fils, Stephane Nikis, Jean-Paul Lechat, Zuzana Javorcikova, Michel Dangoisse, Aline Gillain, Philippe Van der Linden
Publikováno v:
Trials, Vol 22, Iss 1, Pp 1-11 (2021)
Trials
Trials
BackgroundFibromyalgia is a chronic multidimensional pain disease with no curative treatment currently available. Its management relies on a multimodal approach involving pharmacologic and non-pharmacologic elements. Because a suggested factor in its
Autor:
Nathalie de Visscher, Xavier Holemans, Aline Gillain, Anne Kornreich, Raphael Lagasse, Philippe Piette, Manfredi Ventura, Frédéric Thys
BackgroundThe Grand Hôpital de Charleroi is a large non-academic Belgian hospital that treated a large number of COVID-19 inpatients. In the context of this pandemic, all professions-combined healthcare workers (HCWs), and not only direct caregivers
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::30815e03217c4bd7dcef1453aaf6b2ae
https://doi.org/10.1101/2022.03.03.22271855
https://doi.org/10.1101/2022.03.03.22271855
Autor:
Jean-Charles Goeminne, Emmanuel Seront, Petra Boegner, Jean-Pascal Machiels, Aline Gillain, Sylvie Rottey, Jean-Marie Vandenbulcke, Philippe Glorieux, Bertrand Filleul, Vincent Verschaeve, Brieuc Sautois, Aline Van Maanen
Publikováno v:
BJU International. 118:408-415
BACKGROUND: Excessive activation of the PI3K/Akt/mTOR pathway is frequently observed in transitional cell carcinoma (TCC) due to a loss of PTEN and/or activating mutation of PIK3CA. Allosteric mTOR inhibition by everolimus resulted in modest efficacy
Autor:
Sylvie Rottey, Brigitte Vanderschueren, Ingrid Louviaux, Bertrand Filleul, Didier Dequanter, Lionel D'Hondt, Sandra Schmitz, Jean Pascal Machiels, Emmanuel Seront, N. Whenham, Guy Berchem, Brieuc Sautois, Petra Boegner, Dany Brohée, Christel Fontaine, Jean-Marie Vandenbulcke, Christophe Lonchay, Joelle Schoonjans, Aline Gillain, Stéphanie Henry, Aline Van Maanen, Stéphane Holbrechts
Publikováno v:
The Oncologist
The Oncologist, Vol. 21, no. 12, p. 1416-e17 (2016)
The Oncologist, Vol. 21, no. 12, p. 1416-e17 (2016)
Lessons Learned Cabazitaxel has activity in squamous cell carcinoma of the head and neck (SCCHN) and taxane-resistant cell lines. For the first time, cabazitaxel was investigated in incurable patients with recurrent SCCHN. Patients were randomly assi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54ffbae3965bc9b13828b58054618f0d
https://hdl.handle.net/20.500.14017/27c82b0f-b698-4878-92de-961dd4853f3a
https://hdl.handle.net/20.500.14017/27c82b0f-b698-4878-92de-961dd4853f3a
Autor:
Marc Hamoir, Denis Rommel, Birgit Weynand, Sandra Schmitz, Thierry Duprez, François-Xavier Hanin, Max Lonneux, N Cappoen, Michèle Magremanne, Hervé Reychler, Jean-Pascal Machiels, Renaud Lhommel, Nicolas Michoux, Aline Gillain
Publikováno v:
Annals of Oncology. 24:2261-2266
To investigate the safety and activity of cetuximab in the pre-operative treatment of squamous cell carcinoma of the head and neck (SCCHN).Cetuximab was administered for 2 weeks before surgery to 33 treatment-naïve patients selected for primary surg
Autor:
Phillipe Glorieux, Jean-Marie Vandenbulcke, Vincent Verschaeve, Aline Gillain, Sylvie Rottey, Bertrand Filleul, Petra Boegner, Brieuc Sautois, Jean-Charles Goeminne, Emmanuel Seront, Jean-Pascal Machiels, Aline Van Maanen
Publikováno v:
Journal of Clinical Oncology. 33:e15535-e15535
e15535 Background: Excessive activation of the PI3K/Akt/mTOR pathway is frequently observed in TCC, due to loss of PTEN and/or activating mutation of PIK3CA.We previously showed in a phase II trial...